Leyden et al., 2009 - Google Patents
Synthesis of bivalent lactosides based on terephthalamide, N, N′-diglucosylterephthalamide, and glycophane scaffolds and assessment of their inhibitory capacity …Leyden et al., 2009
View PDF- Document ID
- 11776602997451578193
- Author
- Leyden R
- Velasco-Torrijos T
- Andre S
- Gouin S
- Gabius H
- Murphy P
- Publication year
- Publication venue
- The Journal of Organic Chemistry
External Links
Snippet
Glycan recognition by lectins initiates clinically relevant processes such as toxin binding or tumor spread. Thus, the development of potent inhibitors has a medical perspective. Toward this goal, we report the synthesis of both rigid and flexible bivalent lactosides on scaffolds …
- 239000002523 lectin 0 title abstract description 165
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/5308—Immunoassay; Biospecific binding assay for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
- C07H5/10—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Leyden et al. | Synthesis of bivalent lactosides based on terephthalamide, N, N′-diglucosylterephthalamide, and glycophane scaffolds and assessment of their inhibitory capacity on medically relevant lectins | |
| Kulkarni et al. | “One-pot” protection, glycosylation, and protection–glycosylation strategies of carbohydrates | |
| Siebert et al. | Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins | |
| André et al. | Substitutions in the N-glycan core as regulators of biorecognition: the case of core-fucose and bisecting GlcNAc moieties | |
| Dam et al. | Thermodynamic studies of lectin− carbohydrate interactions by isothermal titration calorimetry | |
| André et al. | Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein− carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets | |
| Werz et al. | Exploring the structural diversity of mammalian carbohydrates (“glycospace”) by statistical databank analysis | |
| van Hattum et al. | Tuning the preference of thiodigalactoside-and lactosamine-based ligands to galectin-3 over galectin-1 | |
| Palma et al. | Ligands for the β-glucan receptor, Dectin-1, assigned using “designer” microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides | |
| Roy et al. | Multivalent carbohydrate-lectin interactions: How synthetic chemistry enables insights into nanometric recognition | |
| del Carmen Fernandez-Alonso et al. | Protein-carbohydrate interactions studied by NMR: from molecular recognition to drug design | |
| Lundborg et al. | Structural analysis of glycans by NMR chemical shift prediction | |
| Gupta et al. | Thermodynamics of carbohydrate binding to galectin-1 from Chinese hamster ovary cells and two mutants. A comparison with four galactose-specific plant lectins | |
| Restuccia et al. | Evaluation of self-assembled glycopeptide nanofibers modified with N, N′-diacetyllactosamine for selective galectin-3 recognition and inhibition | |
| Rodriguez et al. | Thermodynamic switch in binding of adhesion/growth regulatory human galectin-3 to tumor-associated TF antigen (CD176) and MUC1 glycopeptides | |
| Dubber et al. | Synthesis of carbohydrate-centered oligosaccharide mimetics equipped with a functionalized tether | |
| Cagnoni et al. | Design and synthesis of hydrolytically stable multivalent ligands bearing thiodigalactoside analogues for peanut lectin and human galectin-3 binding | |
| Campo et al. | Synthetic glycoconjugates inhibitors of tumor-related galectin-3: an update | |
| Zhang et al. | Thiodigalactoside–bovine serum albumin conjugates as high-potency inhibitors of galectin-3: an outstanding example of multivalent presentation of small molecule inhibitors | |
| Hiruma et al. | Rational design and synthesis of a 1, 1-linked disaccharide that is 5 times as active as sialyl Lewis X in binding to E-selectin | |
| Sun et al. | Modular synthesis of heparan sulfate oligosaccharides having N-acetyl and N-sulfate moieties | |
| Denavit et al. | Synthetic inhibitors of galectins: Structures and syntheses | |
| Prescher et al. | Design, synthesis, and biological evaluation of small, high-affinity Siglec-7 ligands: toward novel inhibitors of cancer immune evasion | |
| Beckwith et al. | Calorimetric analysis of the interplay between synthetic Tn antigen-presenting MUC1 glycopeptides and human macrophage galactose-type lectin | |
| André et al. | Carbamate-linked lactose: design of clusters and evidence for selectivity to block binding of human lectins to (neo) glycoproteins with increasing degree of branching and to tumor cells |